Startup

From the beginning, Hims & Hers CEO Andrew Dudum had imagined he would take his startup public through a traditional IPO. But last month, the direct-to-consumer health startup ended up taking a different route. The startup merged with a special-purpose acquisition company formed by Oaktree Capital Management, effectively a shell company that goes public with

Innovaccer Inc.’s Series D funding round has propelled it to unicorn status. The healthcare technology company gained $105 million in its latest funding round, which pushed its valuation to $1.3 billion. The total investment in the company jumped to $225 million, up from $120 million at the end of its Series C round last February.

AppliedVR’s program includes a feature for users to go through guided breathing exercises, which are visualized in a 3-D nature scene. Photo credit: AppliedVR For the past six years, AppliedVR has been distributing VR headsets to hospitals to see if it could help reduce pain and anxiety during what for many patients can be a

Truvian Sciences plans to seek FDA clearance and CLIA certification for its benchtop blood testing device. Photo credit: Truvian Sciences Truvian Sciences, a startup building a benchtop blood analyzer, raised $105 million in funding. The San Diego-based company plans to use the funds to seek 510(k) clearance and a CLIA waiver from the Food and

As investors pour funds into digital tools for musculoskeletal pain, new studies are putting them to the test. Results of one such study, published Tuesday in JAMA Network Open, found that digital physical therapy could be a more effective means of reducing knee pain for patients than standard self-management. A total of 105 people with

Vivor CEO and co-founder Ian Manners talks about the origins of the financial assistance startup and their mission to eliminate out-of-pocket costs as a barrier to care. Why did you start this company? In my previous career as a management consultant, I worked with a lot of pharma companies that were trying to figure out

  Insurance startup Oscar Health plans to raise up to $1.05 billion in its planned IPO, according to paperwork filed on Monday with the Securities and Exchange Commission. The company set a price range of $32 to $34 per share for its stock, which would value the company at up to $6.7 billion. Oscar plans

The MedCity INVEST conference, scheduled for April 19-23, is offering new ways for healthcare startups to connect with investors at the online event. Ask the Investor sessions will provide a way for startups to get insights on investment strategy and to pose questions about funding and more. Austin Duke, Senior Venture Associate, UnityPoint Health Ventures, is

Everlywell got an emergency use authorization from the FDA to sell its Covid-19 test kits without a prescription. Photo credit: Everlywell The Food and Drug Administration ok’d another at-home Covid-19 test to be sold over the counter. At-home testing company Everlywell received an emergency use authorization from the Food and Drug administration on Wednesday to

Even before the pandemic, concierge primary care startup Eden Health saw an opportunity in striking a balance between in-person visits and telehealth. The New York-based company recently raised $60 million in a series C round led by Insight Partners, which it will use to open new brick-and-mortar clinics in additional cities. Eden also plans to

98point6 is rolling out mental health services in some states this month. Photo credit: 98point6 Seeing a spike in demand for mental health services, several digital health companies rolled out virtual therapy or self-guided tools during the pandemic. Text-based primary care startup 98point6 is doing the same. The Seattle-based company is adding a feature this

Cancer patients receive a check-in to see how their immune cells are working and whether the disease is responding to treatment. This immune monitoring is a routine part of cancer care and it helps guide treatment decisions. Yet current analysis methods remain limited, according to Ali Ansary, co-founder and CEO of startup Ozette. The Seattle-based

Gene therapy may offer potential cures, but its promise comes with a price. Some experimental approaches require a multi-step process to prepare stem cells for the procedure—a burden to a patient and to the healthcare system, according to Paula Soteropoulos, executive chair of startup Ensoma. Soteropoulos’s company is proposing an alternative. The Boston-based biotech is

  Medical device company Dexcom is launching its first venture fund. The San Diego-based company, one of a few competing for dominance in the market for continuous glucose monitors, plans to invest in technologies related to its core business and adjacent technologies. Steve Pacelli, Dexcom’s executive vice president of strategy and corporate development, will lead

MedCity News will host its annual INVEST conference online, April 19-23. INVEST is a premier international healthcare investing event hosted in partnership with MHIN, a Midwest healthcare investor organization. The conference brings together active investors and promising startups in biopharma, diagnostics, medical devices, health IT, and health services. INVEST will address six broad themes through a mix of live and pre-recorded

Prompt Health Founder and CEO Hedieh Safiyari talks about her healthcare startup that seeks to provide an online marketplace to connect clients, providers and products in a better way where everybody benefits from smart referrals. Why did you start this company? There is a huge fragmentation in the wellness industry with no effective strategy for

Cyteir Therapeutics’ lead program in cancer is on track to start mid-stage testing later this year and the company plans to support that study with a fresh $80 million in capital, a Series C round of funding that includes the type of investors that could take the company public. Lexington, Massachusetts-based Cyteir develops drugs that

Most in-house attorneys start their careers elsewhere and then end up on the corporate side. Not Maggie Huston, who is an associate general counsel for Tempus, the precision medicine startup based in Chicago. Huston has spent her entire career in-house at healthtech companies, thereby witnessing the industry’s transformation over her 10-year career. That includes a

FlipMD Co-founders Gregory Hanson, MD, MPH, CEO, and Lauren Hanson, COO, talk about why they launched their healthcare startup focused on helping physicians moonlight as consultants and helping healthcare companies fill their expertise gaps for specific projects. Why did you start this company? Greg: As a resident physician, I never imagined building a startup or

The MedCity INVEST conference, scheduled for April 19-23, is offering new ways for healthcare startups to connect with investors at the online event. Ask the Investor sessions will provide a way for startups to get insights on investment strategy and to pose questions about funding and more. Ellen Herlacher Principal, LRVHealth, is one of a handful